Table 1 Demographic and clinical characteristics of subjects with different types of corpus callosum disorders
Characteristic | A (n = 11) | H (n = 47) | D(n = 15) | A vs. H* | A vs. D* | H vs. D* |
|---|---|---|---|---|---|---|
Sex (M) | 8 (72.7%) | 29 (61.7%) | 7 (46.7%) | χ²=0.43, p = 0.51 | χ²=2.24, p = 0.13 | χ²=1.03, p = 0.31 |
Premature/Full-term infants (P/F) | 5/6 (45.5%/54.5%) | 12/35 (25.5%/74.5%) | 6/9 (40%/60%) | χ²=1.67, p = 0.20 | χ²=0.02, p = 0.88 | χ²=0.93, p = 0.34 |
Developing epilepsy | 7 (63.6%) | 19 (40.4%) | 9 (60%) | χ²=2.07, p = 0.15 | χ²=0.06, p = 0.81 | χ²=2.00, p = 0.16 |
Developing ADHD | 3 (27.3%) | 7 (14.9%) | 1 (6.7%) | χ²=1.28, p = 0.26 | χ²=2.29, p = 0.13 | χ²=1.32, p = 0.25 |
Developing developmental delay/intelligence deficiency | 8 (72.7%) | 32 (68.1%) | 12 (80%) | χ²=0.09, p = 0.77 | χ²=0.23, p = 0.63 | χ²=0.59, p = 0.44 |
Combined with other brain abnormalities | 9 (81.8%) | 35 (74.5%) | 15 (100%) | χ²=0.29, p = 0.59 | Fisher’s exact test, p = 0.10 | Fisher’s exact test, p = 0.05 |
The number of people who need more than two epilepsy drugs | 4 (57.1%)†| 10(52.6%)†| 8(88%)†| Fisher’s exact test,p = 0 0.75 | Fisher’s exact test,p = 0 0.14 | χ² =3 0.48,p = 0 0.06 |
Mean ± standard deviation of age (year) | 7 0.3 ± 3 0.8 | 9 0.2 ± 5 0.1 | 11 0.4 ± 5 0.0 | t=-1 0.38,p = 0 0.17 | t=-2 0.30,p = 0 0.03 | t=-1 0.58,p = 0 0.12 |